Skip to main content
. 2020 Oct 31;10(1):109–118. doi: 10.1002/cam4.3575

Figure 4.

Figure 4

Duration of Treatment and Response by Tumor Type and BRCA Mutation Status (RECIST v1.1) in the Overall Population (N = 15). aDiscontinued due to reasons other than AE or PD; bDiscontinued due to AE unrelated to treatment; cDiscontinued due to AE that was possibly treatment related. The first dot for each bar indicates timepoint when best overall response was achieved. Abbreviations: BRCA, breast cancer susceptibility gene; RECIST, Response Evaluation Criteria in Solid Tumors